This Article Full Text Full Text (PDF) All Versions of this Article: 19/10/2491    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Georgescu, S. P. Articles by Mendelsohn, M. E. Search for Related Content PubMed PubMed Citation Articles by Georgescu, S. P. Articles by Mendelsohn, M. E.

Modulator Recognition Factor 1, an AT-Rich Interaction Domain Family Member, Is a Novel Corepressor for Estrogen Receptor

Molecular Cardiology Research Institute (S.P.G., J.H.L., Q.L., R.H.K., M.E.M.), New England Medical Center and Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts 02111; and Division of Molecular and Cellular Oncology (M.B.), Department of Medical Oncology, Dana-Farber Cancer Institute, and Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115

Address all correspondence and requests for reprints to: Michael E. Mendelsohn, Molecular Cardiology Research Institute, New England Medical Center and Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts 02111. E-mail: mmendelsohn{at}tufts-nemc.org.

Cardiovascular tissues are important targets of estrogen action. Vascular cells express the two known estrogen receptors (ERs), ER and ERß, ligand-activated transcription factors that regulate gene transcription through interactions with both coactivator and corepressor molecules. To isolate ER coregulators in vascular cells, we performed a yeast two-hybrid screen for ER-interacting proteins using a human aorta library. Here we report the identification of modulator recognition factor 1 (MRF1) as an ER-interacting corepressor protein. Full-length MRF1 binds to both the N terminus and the C terminus of ER. ER and MRF1 coimmunoprecipitate in an estradiol-independent manner, and recombinant ER binds to both full-length and COOH-terminal MRF1 in the absence of estradiol. MRF1 also interacts in a ligand-dependent manner with thyroid receptor , retinoid X receptor , and androgen receptor, and in a ligand-independent manner with ERß and the retinoic acid receptor. MRF1 RNA is highly expressed in aorta, heart, skeletal muscle, and liver. MRF1 has intrinsic repressor activity in an in vitro GAL reporter assay. Transient transfection studies show that MRF1 represses transcription by ER activated by estradiol in a dose-dependent manner, as well as by the selective ER modulators 4-hydroxy-tamoxifen and raloxifene. MRF1 repression is not influenced by pharmacological inhibition of histone deacetylase. These data identify MRF1 as a repressor of ER-mediated transcriptional activation and support a role for MRF1 in regulating ER-dependent gene expression in cardiovascular and other cells.

NURSA Molecule Pages Link:

Nuclear Receptors:   TRα  |  RARα  |  RXRα  |  ERα  |  ERβ  |  AR

Coregulators:   MRF1

Ligands:   all-trans-Retinoic acid  |  17β-Estradiol  |  Dihydrotestosterone  |  9-cis-Retinoic acid  |  4-Hydroxytamoxifen  |  Thyroid hormone  |  Raloxifene

This article has been cited by other articles:

				H. V. Heemers and D. J. Tindall Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex Endocr. Rev., December 1, 2007; 28(7): 778 - 808. [Abstract] [Full Text] [PDF]

				N. Heldring, A. Pike, S. Andersson, J. Matthews, G. Cheng, J. Hartman, M. Tujague, A. Strom, E. Treuter, M. Warner, et al. Estrogen Receptors: How Do They Signal and What Are Their Targets Physiol Rev, July 1, 2007; 87(3): 905 - 931. [Abstract] [Full Text] [PDF]